Our editorial team scores each provider on pricing transparency, medication quality, prescriber credentials, speed of intake-to-prescription, customer support, and verified patient reviews
July 1 is just around the corner so, hopefully, there will be more guidance coming soon.
The FDAs decision to ban BPC-157 and other peptides stems from concerns over safety, citing insufficient data, impurities, and potential adverse immune reactions
Adding in four new, random peptides in addition to the compounded blend (from what you read on the internet, a podcast or other form of non-medical avenue) is not optimizing the process, its creating the potential for an unwanted hormonal or hematologic cascade
J.GnanamanickamG